Sildenafil Teva
From £3.99
Clinical Evidence for Viagra 100mg Effectiveness
Foundation Clinical Studies
The clinical evidence for Viagra 100mg stems from comprehensive research programmes conducted before and after its approval. Initial pivotal trials demonstrated significant improvements in erectile function compared to placebo, with the 100mg dose showing the highest response rates. These foundational studies involved thousands of participants across different age groups and underlying causes of erectile dysfunction.
Dose-Response Research
Clinical trials specifically examining different sildenafil doses revealed important insights about the 100mg formulation. Research indicates that whilst 50mg serves as the recommended starting dose for most patients, approximately 15-20% may benefit from dose escalation to 100mg when the lower dose proves insufficient. Studies show that patients who do not respond adequately to 50mg may achieve satisfactory results with 100mg, though this higher dose may increase the likelihood of side effects.
Efficacy Across Patient Populations
Research has examined Viagra 100mg effectiveness across diverse patient groups. Studies in men with diabetes-related erectile dysfunction showed response rates of approximately 60-70% with the 100mg dose. Research in patients following prostate surgery demonstrated that sildenafil 100mg could help restore erectile function in selected cases. Post-marketing studies have provided real-world evidence supporting these clinical trial findings.
Safety Profile Research
Extensive safety data exists for Viagra 100mg from both controlled trials and post-marketing surveillance. Research indicates that side effects are generally dose-related, with the 100mg dose associated with higher rates of headache, flushing, and visual disturbances compared to lower doses. However, serious adverse events remain rare when the medication is used appropriately and contraindications are observed. Cardiovascular safety studies have been particularly important given the patient population.
Long-term Use Studies
Research examining long-term sildenafil use has provided valuable insights into sustained effectiveness and safety. Studies following patients for several years indicate that Viagra 100mg maintains its effectiveness over time in most users. Long-term safety data supports continued use when clinically appropriate, though regular medical review remains important.
Comparative Research
Clinical studies comparing branded Viagra with generic sildenafil demonstrate bioequivalence, meaning both formulations deliver the same therapeutic effect. This research supports patient choice between branded and generic options based on preference and cost considerations. EverydayMeds offers both Viagra and sildenafil, allowing patients to select their preferred option during the ordering process.
Current Research Directions
Ongoing research continues to expand understanding of optimal sildenafil use. Recent studies examine factors that might predict which patients benefit most from the 100mg dose, combination approaches with lifestyle interventions, and personalised dosing strategies. This evolving evidence base helps inform clinical practice and treatment decisions.
